Patents by Inventor Eben Alsberg

Eben Alsberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210046220
    Abstract: A composition includes a hydrogel that includes a plurality biodegradable natural polymer macromers crosslinked with a first agent and optionally a plurality of cells dispersed in the crosslinked macromers, the microgels are capable of being crosslinked with a second agent that is different than the first crosslinking agent.
    Type: Application
    Filed: July 25, 2018
    Publication date: February 18, 2021
    Inventors: Eben Alsberg, Oju Jeon, Jung-Youn Shin, Robyn Marks, Mitchell Hopkins, Hong-Hyun Park
  • Patent number: 10729776
    Abstract: A composition includes a plurality of coacervate micro and/or nanodroplets of oxidized alginate and a methacrylated gelatin.
    Type: Grant
    Filed: October 9, 2018
    Date of Patent: August 4, 2020
    Assignee: CASE WESTERN RESERVE UNIVERSITY
    Inventors: Eben Alsberg, Oju Jeon, David Wolfson
  • Publication number: 20200129660
    Abstract: A bioadhesive includes a crosslinked biodegradable hydrogel that includes a plurality of oxidized, acrylated or methacrylated, natural polymer.
    Type: Application
    Filed: December 24, 2019
    Publication date: April 30, 2020
    Inventors: Eben Alsberg, Oju Jeon
  • Patent number: 10512708
    Abstract: A bioadhesive includes a crosslinked biodegradable hydrogel that includes a plurality of oxidized, acrylated or methacrylated, natural polymer. Bioadhesives are natural or synthetic materials that can be used for soft tissue repair to create a seal preventing leakage of biological fluids or to reinforce anatomic integrity as an attractive alternative to sutures and staples. The most widely used bioadhesives are fibrin, cyanoacrylates, and albumin-glutaraldehyde bioadhesives.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: December 24, 2019
    Assignee: CASE WESTERN RESERVE UNIVERSITY
    Inventors: Eben Alsberg, Oju Jeon
  • Publication number: 20190358364
    Abstract: A method of modulating transdifferentiation of chondrocytes to osteoblast includes administering to the chondrocytes an agent that modulates GP130 receptor signaling and expression of at least one of Sox2, Oct4, or Nanog of the chondrocytes.
    Type: Application
    Filed: December 11, 2017
    Publication date: November 28, 2019
    Inventors: Eben Alsberg, Oju Jeon, Ralph Marcucio, Chelsea Bahney, Diane Hu, Sarah Knox
  • Publication number: 20190298883
    Abstract: A method of forming an insoluble native collagen fiber additive, includes soaking the decellularized tissue powder, which includes collagen fibers, in acidic or basic, salt solution, enzymatically dissociating the insoluble collagen fibers, and isolating insoluble native collagen fibers from the solution. The isolated insoluble collagen fibers can be used in cell aggregates and/or tissue constructs to provide three dimensional cell growth and/or adhesion.
    Type: Application
    Filed: April 1, 2019
    Publication date: October 3, 2019
    Inventors: Eben Alsberg, Rui Tang
  • Publication number: 20190298656
    Abstract: A composition includes a plurality of particulate coated hydrogel microparticles, each of the microparticles including a hydrogel inner core and a particulate shell defined by a plurality of solid nanoparticles, the particulate shell inhibiting aggregation of the microparticles in an aqueous medium and being permeable to allow release of agents from the hydrogel inner core.
    Type: Application
    Filed: April 1, 2019
    Publication date: October 3, 2019
    Inventors: Eben Alsberg, Rui Tang
  • Publication number: 20190112434
    Abstract: An elastomeric nanocomposite hydrogel includes first natural polymer macromers covalently crosslinked with second natural polymer macromer and physically crosslinked with a plurality of inorganic nanoparticles. The elastomeric nanocomposite hydrogel is cytocompatible, and, upon degradation, produce substantially non-toxic products.
    Type: Application
    Filed: December 12, 2018
    Publication date: April 18, 2019
    Inventors: Eben Alsberg, Oju Jeon
  • Publication number: 20190105395
    Abstract: A cytocompatible hydrogel includes a plurality first polymer macromers linked to a plurality of second polymer macromers different than the first polymer macromers by a plurality of ?-hydroxythio-ether linkages, and a plurality of cells encapsulated in the hydrogel.
    Type: Application
    Filed: October 5, 2018
    Publication date: April 11, 2019
    Inventors: Eben Alsberg, Fangze Liu, Yuxuan Cheng, Katherine A. Coughlin
  • Publication number: 20190060467
    Abstract: A composition includes a plurality of coacervate micro and/or nanodroplets of oxidized alginate and a methacrylated gelatin.
    Type: Application
    Filed: October 9, 2018
    Publication date: February 28, 2019
    Inventors: Eben Alsberg, Oju Jeon, David Wolfson
  • Publication number: 20190054206
    Abstract: A method for forming a bioactive agent spatially patterned includes providing a photocrosslinkable hydrogel that includes a photocrosslinkable base polymer, photocrosslinkable bioactive agent coupling polymer macromers, and at least one bioactive agent that couples to the photocrosslinkable bioactive agent coupling polymer macromer, an selectively exposing discrete portions of the photocrosslinkable hydrogel to actinic radiation effective to initiate cross-linking of the base polymer and the bioactive agent coupling polymer macromers at the exposed portions.
    Type: Application
    Filed: August 21, 2018
    Publication date: February 21, 2019
    Inventors: Eben Alsberg, Oju Jeon, Keewon Lee
  • Publication number: 20190054207
    Abstract: A composition includes a dual crosslinkable hydrogel that includes a plurality of polymer macromers, which are crosslinked with a first agent and a second agent different than the first agent, wherein the crosslinks formed using the second agent are reversible and repeatable to allow the mechanical properties of the hydrogel to be dynamically adjusted.
    Type: Application
    Filed: August 21, 2018
    Publication date: February 21, 2019
    Inventors: Eben Alsberg, Oju Jeon, Tae-Hee Kim
  • Publication number: 20190054211
    Abstract: An interpenetrating polymer network (IPN) structured hydrogel includes a crosslinked first natural polymer macromer with a first elasticity and an interpenetrating network of crosslinked second natural polymer macromers having a second elasticity higher than the first elasticity, the IPN structured hydrogel being cytocompatible, and, upon degradation, produce substantially non-toxic products.
    Type: Application
    Filed: August 21, 2018
    Publication date: February 21, 2019
    Inventor: Eben Alsberg
  • Publication number: 20180371416
    Abstract: A tissue construct comprising includes a self-assembled, scaffold-free, high-density cell aggregate. The cell aggregate includes a plurality of cells and a plurality of biocompatible and biodegradable nanoparticles and/or microparticles that are incorporated within the cell aggregate. The nanoparticles and/or microparticles act as a bulking agent within the cell aggregate to increase the cell aggregate size and/or thickness and improve the mechanical properties of the cell aggregate allowing the cell aggregate to be readily manipulated and formed into tissue constructs with defined architectures.
    Type: Application
    Filed: July 24, 2018
    Publication date: December 27, 2018
    Inventors: Eben Alsberg, Loran Solorio, Phuong Dang
  • Patent number: 10092654
    Abstract: A composition includes a plurality of coacervate micro and/or nanodroplets of oxidized alginate and a methacrylated gelatin.
    Type: Grant
    Filed: July 9, 2015
    Date of Patent: October 9, 2018
    Assignee: Case Western Reserve University
    Inventors: Eben Alsberg, Oju Jeon, David Wolfson
  • Patent number: 10030228
    Abstract: A tissue construct comprising includes a self-assembled, scaffold-free, high-density cell aggregate. The cell aggregate includes a plurality of cells and a plurality of biocompatible and degradable nanoparticles and/or microparticles that are incorporated within the cell aggregate. The nanoparticles and/or microparticles act as a bulking agent and/or provide bioactive agents or signals within the cell aggregate to increase the cell aggregate size and/or thickness and improve the mechanical properties of the cell aggregate and/or regulate cell function within the aggregate allowing the cell aggregate to be readily manipulated and formed into tissue constructs with defined architectures and potential tissue specific functionality.
    Type: Grant
    Filed: April 15, 2013
    Date of Patent: July 24, 2018
    Assignee: Case Western Reserve University
    Inventors: Eben Alsberg, Loran Solorio, Phuong Dang
  • Publication number: 20180064851
    Abstract: A modular engineered tissue construct includes a plurality of fused self-assembled, scaffold-free, high-density cell aggregates. At least one cell aggregate includes a plurality of cells and a plurality of biocompatible and biodegradable nanoparticles and/or microparticles that are incorporated within the cell aggregates. The nanoparticles and/or microparticles acting as a bulking agent within the cell aggregate to increase the cell aggregate size and/or thickness and improve the mechanical properties of the cell aggregate as well as to deliver bioactive agents.
    Type: Application
    Filed: September 7, 2017
    Publication date: March 8, 2018
    Inventors: Eben Alsberg, Anna D. Dikina, Marsha W. Rolle, Hannah A. Strobel
  • Publication number: 20170183629
    Abstract: A modular engineered tissue construct includes a plurality of fused self-assembled, scaffold-free, high-density cell aggregates. At least one cell aggregate includes a plurality of cells and a plurality of biocompatible and biodegradable nanoparticles and/or microparticles that are incorporated within the cell aggregates. The nanoparticles and/or microparticles acting as a bulking agent within the cell aggregate to increase the cell aggregate size and/or thickness and improve the mechanical properties of the cell aggregate as well as to deliver bioactive agents.
    Type: Application
    Filed: March 9, 2015
    Publication date: June 29, 2017
    Inventors: Eben Alsberg, Anna D. Dikina, Marsha W. Rolle
  • Patent number: 9642914
    Abstract: A photocrosslinked biodegradable hydrogel includes a plurality of natural polymer macromers cross-linked with a plurality of hydrolyzable acrylate cross-links. The hydrogel is cytocompatible and produces substantially non-toxic products upon degradation.
    Type: Grant
    Filed: August 31, 2012
    Date of Patent: May 9, 2017
    Assignee: Case Western Reserve University
    Inventors: Eben Alsberg, Oju Jeon
  • Publication number: 20160022862
    Abstract: A bioadhesive includes a crosslinked biodegradable hydrogel that includes a plurality of oxidized, acrylated or methacrylated, natural polymer. Bioadhesives are natural or synthetic materials that can be used for soft tissue repair to create a seal preventing leakage of biological fluids or to reinforce anatomic integrity as an attractive alternative to sutures and staples. The most widely used bioadhesives are fibrin, cyanoacrylates, and albumin-glutaraldehyde bioadhesives.
    Type: Application
    Filed: March 7, 2014
    Publication date: January 28, 2016
    Inventor: Eben Alsberg